New York, USA — September 25, 2025: On the sidelines of the United Nations General Assembly, Prime Minister Gaston Browne of Antigua and Barbuda co-chaired a high-level Clinton Global Initiative (CGI) roundtable titled ‘Political Action & Investment for Mental Health Equity.’ The event, held in collaboration with Dr. Jarbas Barbosa, Director of the Pan American Health Organization (PAHO/WHO), brought together government officials, health agencies, philanthropists, and private investors to transform commitments into scalable, funded programs across Small Island Developing States (SIDS) and the Americas. Prime Minister Browne emphasized that mental health is a critical development and productivity issue, urging for policy reforms supported by sustainable financing, measurable outcomes, and accessible services integrated into schools, workplaces, and communities. He stated, ‘Mental health equity demands political will and real money. For small islands on the climate frontline, investing in mental health is an investment in resilience, productivity, and human dignity.’ Key discussions highlighted the economic impact of untreated mental health issues, which cost the global economy trillions in lost productivity. Participants agreed on the necessity of integrating mental health into schools and workplaces, embedding psychosocial support in disaster preparedness, and addressing climate-related mental health challenges such as PTSD, anxiety, and eco-anxiety. The roundtable also explored financing strategies, advocating for the alignment of public budgets, philanthropy, and private capital to expand primary health care, suicide prevention programs, workforce training, and digital mental health access. Prime Minister Browne announced plans to co-host a Regional Mental Health Summit in Antigua and Barbuda in 2026 with PAHO, focusing on actionable outcomes, including primary care integration, youth mental health, and climate-related psychosocial support.
分类: health
-

Bellevue Hospital CEO cops top honour at Australian Mental Health Foundation awards
KINGSTON, Jamaica — Suzette Buchanan, CEO of Bellevue Hospital, has been awarded the prestigious title of International Mental Health Advocate of the Year by the Mental Health Foundation Australia (MHFA). Buchanan will travel to Melbourne on October 4 to receive the accolade at the 8th Annual Australian Mental Health Awards, coinciding with Australia’s National Multicultural Mental Health Month. She is among six honorees recognized this year for their exceptional contributions to mental health awareness and stigma reduction. Buchanan’s leadership at Bellevue Hospital and her role as host of the groundbreaking mental health television series *MindSet* were key factors in her selection. With over 14 years of experience in health, media, and public service governance, Buchanan has championed national reforms and combatted mental health stigma through both policy and storytelling. A Harvard-trained Mental Health Leadership graduate, she combines strategic vision with personal experience and empathy, ensuring her work prioritizes individuals and communities. “This award is deeply personal. My work at Bellevue, the creation of *MindSet*, and supporting my daughter living with bipolar disorder have driven my mission to break the silence and dismantle stigma,” Buchanan shared. She dedicated the honor to individuals and families facing mental health challenges, including the over 400 unsupported social cases at Bellevue Hospital, reaffirming her commitment to advocacy, awareness, and healing. Buchanan’s recognition highlights Jamaica’s expanding influence in global mental health advocacy, positioning the nation as a key contributor to international discussions on care, resilience, and stigma reduction. The Mental Health Foundation Australia, the country’s oldest mental health association, celebrates innovative and impactful leadership in mental health through its awards, emphasizing the value of cross-cultural collaboration and diverse perspectives in shaping global mental health strategies.
-

OP-ED: Why back-to-school time shouldn’t mean back to unhealthy food marketing
As a parent navigating the ‘First Day of School’ milestone, the experience was both exhilarating and daunting. Months of preparation went into gathering essentials for my toddler’s preschool journey. However, this transition also unveiled a troubling reality: the pervasive and unethical marketing of unhealthy, ultra-processed foods targeted at children. These products, often disguised as lunchbox necessities, are cleverly designed to appeal to young minds, undermining efforts to promote healthy eating habits.
-

Paracetamol does not cause autism, says expert
Santo Domingo – The World Health Organization (WHO) has officially stated that there is no scientific evidence connecting the use of paracetamol during pregnancy to autism in children. This declaration comes in response to recent assertions made by former U.S. President Donald Trump, who advocated for limiting the use of Tylenol (a brand of paracetamol) among pregnant women and newborns. The WHO’s stance aims to dispel misinformation and reassure the public about the safety of this widely used medication. Dr. Rafael Montero, a public health specialist, strongly criticized Trump’s comments during an interview on Esto No Tiene Nombre, labeling them as baseless and unsupported by scientific research. Montero explained that paracetamol, whose active ingredient is acetaminophen, has been safely utilized for decades with no evidence linking it to autism spectrum disorder. He attributed the increase in autism diagnoses to enhanced detection methods and greater public awareness rather than medication use. Montero also pointed out that Trump had misinterpreted a Johns Hopkins meta-analysis, presenting it as conclusive evidence when it was not. Additionally, he questioned Trump’s focus on the Tylenol brand instead of the active compound, deeming it inappropriate. Montero emphasized the importance of patients consulting their healthcare providers for medical advice, a position echoed by the Dominican Society of Gynecologists, which reaffirmed the safety of acetaminophen when prescribed.






